Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Shaun Chilton to take over as Chief Executive at Clinigen Shaun Chilton to take over as Chief Executive at Clinigen Peter George will step down after six years on 11 November New UK Sales Director for Rockwell Automation New UK Sales Director for Rockwell Automation Mark Bottomley takes a new role at the industrial automation specialist Saneca Pharma strengthens senior team Saneca Pharma strengthens senior team Adds new Sales and Marketing Director and Project Development Manager Priorclave appoints new Service Manager Priorclave appoints new Service Manager Promotes Ranjit Rai, who has almost 25 years of experience in the firm's service department Patrick Shea joins Egalet as Chief Commercial Officer Patrick Shea joins Egalet as Chief Commercial Officer He will be responsible for developing and implementing the firm's commercialisation strategy Novasep appoints Dr François D’Hooge as bioconjugation unit manager Novasep appoints Dr François D’Hooge as bioconjugation unit manager Dr D'Hooge will manage Novasep’s new ADC production unit in Le Mans, France Catalent hires a new Director of R&D, Bioanalytical Chemistry Catalent hires a new Director of R&D, Bioanalytical Chemistry William Haskins will lead bioanalytical chemistry activities that support Catalent’s SMARTag technology Concept Life Sciences intensifies push into medicinal chemistry with new senior appointment at Peakdale Molecular Concept Life Sciences intensifies push into medicinal chemistry with new senior appointment at Peakdale Molecular Dr Paul Bradley becomes Head of Chemistry at the Sandwich, Kent-based company Ex-Pfizer aseptic manufacturing expert Paul Gold joins Vanrx Board of Directors Ex-Pfizer aseptic manufacturing expert Paul Gold joins Vanrx Board of Directors Gold has vast experience of the production of sterile injectable pharmaceuticals Jubilant Biosys strengthens its leadership team with two key appointments Jubilant Biosys strengthens its leadership team with two key appointments Hires Steven Hutchins as President and Dr Takeshi Yuri as VP of Medicinal Chemistry GSK names new Chief Executive GSK names new Chief Executive Emma Walmsley, currently head of GSK's Consumer Healthcare division, will succeed Andrew Witty CiToxLAB hires Alan Bartlett as Senior Director, Global Laboratory Operations CiToxLAB hires Alan Bartlett as Senior Director, Global Laboratory Operations Bartlett will be based at the contract research organisation's Laval site in North America XenoGesis aims to expand into US market XenoGesis aims to expand into US market Appoints Sabrina Mogle as a business development specialist to spearhead growth in the region DS Biopharma appoints new Chief Operating Officer DS Biopharma appoints new Chief Operating Officer Dr Markus Weissbach moves to new role from Medical Director ClinTec International expands US management team ClinTec International expands US management team Rick Farris appointed Executive Vice-President of North American Operations Strategic appointment at Brenntag UK & Ireland Strategic appointment at Brenntag UK & Ireland Brenntag UK & Ireland announces the appointment of Tamara Durak to the position of Pharma & Cosmetics Business Manager Helix BioPharma appoints new Director Helix BioPharma appoints new Director Dr Theordore J. Witek brings more than three decades of clinical development, medical affairs and commercial experience Silence Therapeutics appoints Dmitry Samarsky as Chief Scientific Officer and Dr Andy Richards as Non-Executive Director Silence Therapeutics appoints Dmitry Samarsky as Chief Scientific Officer and Dr Andy Richards as Non-Executive Director Silence's technology harnesses the body’s natural mechanisms to create therapeutic effects within its cells PureTech's Gelesis appoints chief operating officer and vice president of medical affairs PureTech's Gelesis appoints chief operating officer and vice president of medical affairs Former Boehringer Ingelheim vice president will lead commercialisation and operations efforts Vaximm appoints Dr Matthias Schroff as Chief Executive Officer Vaximm appoints Dr Matthias Schroff as Chief Executive Officer Dr Schroff joins the Swiss/German biotechnology firm with more than 15 years of experience Scientific Analysis Laboratories (SAL) welcomes Simon Cliff as Business Development Manager Scientific Analysis Laboratories (SAL) welcomes Simon Cliff as Business Development Manager Cliff has more than 20 years of experience of business development in the laboratory testing industry Crown Bioscience expands leadership team Crown Bioscience expands leadership team Two people join the cardiovascular and metabolic disease portfolio at the US research services firm TapImmune appoints Michael J. Loiacono as Chief Financial Officer TapImmune appoints Michael J. Loiacono as Chief Financial Officer Loiacono will also act as Corporate Secretary TxCell appoints Biogen’s Dr Olivier Danos to its Scientific Advisory Board TxCell appoints Biogen’s Dr Olivier Danos to its Scientific Advisory Board TxCell's Scientific Advisory Board now includes four world-leading immunology experts
  • Previous
  • 1
  • …
  • 57
  • 58
  • 59
  • 60 (current)
  • 61
  • 62
  • 63
  • …
  • 141
  • Next

Trending Articles

  1. THX Pharma appoints Julien Veys as deputy chief executive officer Leadership appointment supports the company’s strategy to advance regulatory approval and commercialization of rare neurology therapies
  2. Kindeva announces leadership transition to support strategic growth David Stevens assumes CEO role as part of a planned succession strategy
  3. Astoriom appoints Will Edwards as Chief Executive Officer Strategic appointment to support global scale-up of sample management operations
  4. Rentschler Biopharma appoints Detra Glinatsis as head of U.S. business development Glinatsis returns to lead U.S. growth strategy and build on Milford site expansion
  5. Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO Appointment supports NanoSyrinx’s transition from platform development to clinical-stage intracellular medicines

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.